CM-24 and Nivolumab - Dose Escalation
FW-2020-1
Phase 2 small_molecule completed
Quick answer
CM-24 and Nivolumab - Dose Escalation for Solid Tumor is a Phase 2 program (small_molecule) at PURPLE BIOTECH LTD. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PURPLE BIOTECH LTD.
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed